Genedrive Plc is a holding company, which engages in the development of drugs and disease diagnostics. It operates through the Diagnostics segment, which is responsible for the commercialization of the Genedrive Point of Need molecular testing platform. The company was founded by Catherine Booth and Christopher Potten on February 15, 2007 and is headquartered in Manchester, the United Kingdom.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company